IDT Biologika is a global biopharmaceutical contract development and manufacturing organization (CDMO) that specializes in the production of breakthrough vaccines and biologics to improve human health.
IDT Biologika uses innovative technologies to advance our clients’ vaccine and biologics to prevent and treat diseases that impact the health of people worldwide.
Over the last decade, IDT has created an enviable track record and expertise in live virus and bacteria vaccines technologies encompassing over 50 promising and breakthrough vaccine projects for clinical trials.
IDT Biologika offers clients a single source CDMO partner with seamless end-to-end solutions and the ability to nimbly scale projects from pre-clinical to commercialization.
Our core competencies in viral vaccines (live and attenuated) and injectable biologics are underscored by our commitment to quality and operational excellence that flows through our best-in-class process and cGMP (and up to BSL2) manufacturing capabilities.